BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 11193807)

  • 1. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.
    Poirier J; Sévigny P
    J Neural Transm Suppl; 1998; 53():199-207. PubMed ID: 9700658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1999 Mar; 24(2):147-53. PubMed ID: 10212558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
    Poirier J
    Trends Neurosci; 1994 Dec; 17(12):525-30. PubMed ID: 7532337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of lipoprotein receptors in Alzheimer's disease.
    Jaeger S; Pietrzik CU
    Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J
    Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
    Chai AB; Lam HHJ; Kockx M; Gelissen IC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
    Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
    Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease.
    Poirier J
    Mol Diagn; 1999 Dec; 4(4):335-41. PubMed ID: 10671644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice.
    Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J
    Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why lipids are important for Alzheimer disease?
    Hirsch-Reinshagen V; Burgess BL; Wellington CL
    Mol Cell Biochem; 2009 Jun; 326(1-2):121-9. PubMed ID: 19116777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations.
    Guillaume D; Bertrand P; Dea D; Davignon J; Poirier J
    J Neurochem; 1996 Jun; 66(6):2410-8. PubMed ID: 8632164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.